Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

Trading 01-22 14:30:54 EST

1,807.10

+34.67

+1.96%

High1,819.78	Low1,769.92	Vol10.67M
Open1,772.39	D1 Closing1,772.43	Amplitude2.81%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O806.24M	T/O Rate--	Tradable Shares0.00
P/B4.24046	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1807.1011,"timestamp":1769110253807,"preClose":1772.4296,"halted":0,"volume":10672816,"delay":0,"changeRate":0.019562,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":34.671509,"latestTime":"01-22 14:30:54 EST","open":1772.3903,"high":1819.7797,"low":1769.9186,"amount":806238523.459821,"amplitude":0.028131,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1769115600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.24046,"peRate":36.114717,"turnoverRate":0.003981,"increases":7,"decrements":3,"flats":0,"marketCap":201043266775.375,"floatMarketCap":200454625836.125},"requestUrl":"/m/hq/s/BK4583/wiki","defaultTab":"wiki","newsList":[{"id":"2605849875","title":"Tonix Pharmaceuticals Showcases Pipeline Progress and Fibromyalgia Drug Launch in Investor Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2605849875","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605849875?lang=en_us&edition=fundamental","pubTime":"2026-01-22 19:36","pubTimestamp":1769081811,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals Holding Corp. has released an investor presentation highlighting its current business operations and financial position. The company reports having three FDA-approved products focused on central nervous system and immunology therapeutic areas. As of September 30, 2025, Tonix holds approximately $190 million in cash and has no debt, with an expected cash runway into the first quarter of 2027. The company operates as a fully integrated organization encompassing research, development, manufacturing, and commercial activities, and maintains partnerships with major universities and the US federal government. A key focus is the commercial rollout of TONMYA for fibromyalgia, with a reported U.S. market of 10 million patients. TONMYA is offered at a wholesale acquisition cost of $1,860 for a 60-count and $930 for a 30-count package, targeting specific patient populations. The company has deployed 90 sales representatives and is focusing on 5% of healthcare providers who w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL6pyHgv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNXP","BK4583","BK4139"],"gpt_icon":0},{"id":"2605461815","title":"Analysts Offer Insights on Healthcare Companies: Novartis AG (NOVN), BioVersys AG (Six Swiss: CH:BIOV) and Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605461815","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605461815?lang=en_us&edition=fundamental","pubTime":"2026-01-22 17:04","pubTimestamp":1769072667,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novartis AG (CH:NOVN – Research Report), BioVersys AG (CH:BIOV – ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novartis-ag-novn-bioversys-ag-six-swiss-chbiov-and-gilead-sciences-gild-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novartis-ag-novn-bioversys-ag-six-swiss-chbiov-and-gilead-sciences-gild-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0058720904.USD","BK4578","BK4550","LU1430594728.SGD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","BK4588","LU0882574055.USD","IE00BSNM7G36.USD","XBI","BK4568","LU0234570918.USD","LU1571399168.USD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4585","LU0320765992.SGD","LU0128526141.USD","LU0889565916.HKD","LU0109394709.USD","AG","LU1066053197.SGD","IE00B7SZLL34.SGD","LU1585245621.USD","LU1778281490.HKD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4210","LU2468319806.SGD","GILD","LU2324357040.USD","LABU","LU1674673428.USD","BK4566","LU2089984988.USD","BK4532","LU0114720955.EUR","LU1674673691.USD","SG9999015952.SGD","BK4583","XLV","IE0002270589.USD","BK4139","LU0823416689.USD","LU1066051498.USD","SG9999015945.SGD","LU0029874061.USD","HCSG","SG9999015978.USD"],"gpt_icon":0},{"id":"2605458902","title":"Analysts Conflicted on These Healthcare Names: Insulet (PODD) and Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605458902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605458902?lang=en_us&edition=fundamental","pubTime":"2026-01-22 09:50","pubTimestamp":1769046633,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Insulet (PODD – Research Report) and Gilead Scienc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-insulet-podd-and-gilead-sciences-gild-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-insulet-podd-and-gilead-sciences-gild-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4137","IE00BKVL7J92.USD","BK4585","SG9999015978.USD","HCSG","IE0002270589.USD","BK4568","PODD","SG9999015986.USD","BK4550","LU0029874061.USD","IE00B3T34201.USD","BK4139","BK4532","LU2065169927.USD","LU1585245621.USD","LU1839511570.USD","LU0109394709.USD","LU2065171402.SGD","LU0889565916.HKD","BK4578","LU1119994496.HKD","XBI","LU1571399168.USD","LU2087621335.USD","BK4581","LU0728928796.USD","LU2065171311.SGD","BK4588","IE00B19Z3B42.SGD","LU1778281490.HKD","LU2468319806.SGD","XLV","SG9999015952.SGD","LU0058720904.USD","IE00B7SZLL34.SGD","LABU","LU1084165304.USD","LU1066053197.SGD","LU1674673428.USD","GILD","IE00BZ1G4Q59.USD","LU0320765992.SGD","BK4583","SG9999015945.SGD","LU0823416689.USD","BK4566","LU0289739699.SGD","LU0882574055.USD"],"gpt_icon":0},{"id":"2605391824","title":"Gilead Sciences Reports Publication of Phase 3 Trial Results of Trodelvy and Keytruda for Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2605391824","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605391824?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:59","pubTimestamp":1769036360,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said late Wednesday that The New England Journal of Medicine published full results from its phase 3 trial of Trodelvy and Keytruda for first-line PD-L1+ metastatic triple-negative breast cancer that met its primary endpoint of progression-free survival, with a 35% reduced risk of disease progression or death compared with Keytruda plus chemotherapy treatment.Median PFS with Trodelvy plus Keytruda was 11.2 months compared with 7.8 months for Keytruda in combination with chemotherapy, the company said.The safety profile of the drug regimen was consistent with the known safety profile of each agent, and no new safety signals were identified, according to a statement.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","SG9999001176.USD","LU1989772840.SGD","LU1941712348.USD","LU0122379950.USD","SG9999015986.USD","LU1116320901.HKD","BK4139","BK4532","LU0648001328.SGD","LU1674673691.USD","LU2361044949.HKD","LU0965509101.SGD","LU0320765646.SGD","LU0234572021.USD","LU1061106388.HKD","SG9999014542.SGD","LU1983299246.USD","LU0098860793.USD","LU0130517989.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU0203347892.USD","LU2023250843.SGD","BK4583","LU0823416689.USD","LU0980610538.SGD","SG9999002232.USD","LU2087621335.USD","BK4559","LU1989771016.USD","IE0002270589.USD","LU1934455863.HKD","LU1201861249.SGD","LU2106854487.HKD","LU1066051498.USD","SG9999015978.USD","BK4550","LU0106261372.USD","LU0211331839.USD","SG9999013999.USD","IE00B19Z3581.USD","IE0009355771.USD","IE00BBT3K403.USD","LU1057294990.SGD","BK4534","IE0002141913.USD","LU1934455194.USD","LU1162221912.USD","LU1430594728.SGD","IE000M9KFDE8.USD","LU1839511570.USD","LU2461242641.AUD","LU0130102774.USD","LU2324357040.USD","LU1571399168.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU1037948897.HKD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","BK4588","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU1066051811.HKD","IE00B7SZLL34.SGD","LU1929549753.HKD","LU0985320562.USD","SG9999014567.USD","LU1989772923.USD","SG9999015945.SGD","LU1093756168.USD","LU0006306889.USD","LU1941712264.USD","LU0882574055.USD","LU0234570918.USD","IE00BKVL7J92.USD","SG9999014575.USD","LU0265550359.USD","LU2361044865.SGD","LU1291159041.SGD","LU2112291526.USD","SG9999015341.SGD","LU2360032135.SGD","SG9999001440.SGD","LU0208291251.USD","LU1116320737.USD","LU2125154935.USD","LU2361045086.USD","LU1037948541.HKD","LU0320765489.SGD","LU0889565916.HKD","BK4578","LU1035773651.USD","LU1917777945.USD","LU0965508806.USD","LU1093756325.SGD","LU0265550946.USD","LU0266013472.USD","LU2089984988.USD","LU1066053197.SGD","BK4533","GILD","LU0320765992.SGD","LU0965509010.AUD","IE00B4R5TH58.HKD","SG9999001176.SGD","IE00BJT1NW94.SGD","LU1066051225.USD","SG9999014559.SGD","LU0238689110.USD","LU1934455277.USD","BK4568","LU0070302665.USD","LU1069347547.HKD","IE00B3T34201.USD","LU1585245621.USD","LU1974910355.USD","LU0109394709.USD","LU0965509283.SGD","BK4007","LU0477156953.USD","LU0203345920.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU0114720955.EUR","SG9999002224.SGD","LU2023250504.SGD","LU1699723380.USD","SG9999015952.SGD","LU0861579265.USD","LU0058720904.USD","BK4516","LU1023059063.AUD","IE00BN8TJ469.HKD","LU1674673428.USD","IE00BZ1G4Q59.USD","SG9999015358.SGD","BK4566","LU2125154778.USD","LU0289739699.SGD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2605437436","title":"DaVita Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2605437436","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605437436?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:20","pubTimestamp":1769034000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  rallied 2.28% to $106.30 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.16% to 6,875.62 and the Dow Jones Industrial Average  rising 1.21% to 49,077.23.The stock's rise snapped a two-day losing streak.DaVita Inc. closed 40.81% below its 52-week high of $179.60, which the company reached on January 31st.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as UnitedHealth Group Inc.  rose 2.75% to $347.75, Icon PLC  rose 4.70% to $184.87, and Quest Diagnostics Inc.  fell 2.28% to $184.65.Data source: Dow Jones Market Data, FactSet. Data compiled January 21, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU0820561909.HKD","LU2552382058.USD","IE00B894F039.SGD","LU2357305700.SGD","LU0175139822.USD","LU0795875086.SGD","LU1267930813.SGD","IE0004445015.USD","IE00B4JS1V06.HKD","SG9999014914.USD","IE0009355771.USD","BK4583","IE00B19Z3581.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU1153585028.USD","LU1674673691.USD","LU1057294990.SGD","IE00B19Z9Z06.USD","LU0994945656.USD","LU0354030438.USD","LU2211815571.USD","LU0097036916.USD","LU0310800379.SGD","LU0689472784.USD","LU0353189680.USD","LU0353189763.USD","LU1084165304.USD","LU2491050154.USD","LU0728928796.USD","LU0950375773.USD","SG9999018857.SGD","LU1267930490.SGD","LU2461242641.AUD","LU2089284900.SGD","LU0943347566.SGD","BK4581","LU1003077747.HKD","LU1814569148.SGD","LU0820561818.USD","LU0052756011.USD","IE00BWXC8680.SGD","LU2023251221.USD","SG9999001176.SGD","LU2362541513.USD","IE0005OL40V9.USD","LU1074936037.SGD","LU1066051811.HKD","LU1934455863.HKD","LU0965509101.SGD","LU2361044865.SGD","LU1720051108.HKD","SG9999002232.USD","LU0738911758.USD","LU0820562030.AUD","IE0002141913.USD","IE00B775H168.HKD","LU1066053197.SGD","LU1988902786.USD","LU0545039389.USD","LU0158827781.USD","LU1069347547.HKD","LU0342679015.USD","LU0661504455.SGD","LU2362541273.HKD","LU2347655156.SGD","LU0234572021.USD","LU2265009873.SGD","LU1989771016.USD","LU0149725797.USD","LU2506952097.USD","SGXZ31699556.SGD","LU0077335932.USD","IE00B19Z8W00.USD","LU1064131342.USD","LU1267930573.SGD","LU2264538146.SGD","LU0672654240.SGD","LU0889566641.SGD","LU1670627923.USD","LU2506951958.HKD","SG9999001176.USD","LU1791710582.SGD","LU0949170772.SGD","SGXZ99366536.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1670628061.USD","LU0211326839.USD","IE00B4R5TH58.HKD","BK4532","LU0158827948.USD","LU0557290698.USD","LU0289739343.SGD","LU1291159041.SGD","LU1934455194.USD","LU1043141123.HKD","LU2112291526.USD","LU0792757196.USD","LU0069063385.USD","IE00B1XK9C88.USD","LU0011850046.USD","SG9999014906.USD","LU1043141396.HKD","LU0823417737.USD","LU1506573853.SGD","IE00BN29S564.USD","LU1804176565.USD","LU1323610961.USD","LU1732799900.SGD","LU2468319806.SGD","SGXZ81514606.USD","LU0251132253.USD","IE00B19Z9505.USD","LU0187121727.USD","LU0345770993.USD","LU0861579265.USD","LU0256863811.USD","LU0316494557.USD","LU0823417653.USD","LU0310800965.SGD","LU0107464264.USD","BK4559","BK4585","LU0320765059.SGD","LU0354030511.USD","LU0787776722.HKD","LU0912757837.SGD","LU2028103732.USD","LU0057025933.USD","LU0128525929.USD","LU0708995401.HKD","LU1037948897.HKD","LU2552382215.SGD","LU0048584097.USD","IE00B1BXHZ80.USD","LU0238689110.USD","LU1061106388.HKD","LU2089984988.USD","LU1718418525.SGD","LU2133065610.SGD","SG9999013999.USD","LU0058720904.USD","LU1035773651.USD","LU0079474960.USD","LU1496350502.SGD","SG9999018865.SGD","LU1023059063.AUD","LU0417517546.SGD","LU0128525689.USD","LU0426412945.USD","IE00BFSS8Q28.SGD","LU1914381329.SGD","LU2362540622.SGD","IE00BZ1G4Q59.USD","LU2111349929.HKD","LU1551013425.SGD","SGXZ51526630.SGD","LU0289739699.SGD","LU1261432733.SGD","LU2361045086.USD","LU0289961442.SGD","IE000M9KFDE8.USD","LU1854103824.USD","IE0004445239.USD","LU1691799644.USD","LU1854104046.USD","LU2125154778.USD","LU2360032135.SGD","LU0114720955.EUR","LU2506951875.HKD","LU0029864427.USD","IE00BFSS7M15.SGD","LU2242649171.HKD","LU0211327993.USD","LU0122379950.USD","BK4533","LU1934455277.USD","LU0511384066.AUD","SG9999017495.SGD","LU0496365809.HKD","LU0310799852.SGD","DVA","LU1119994496.HKD","LU2491050071.SGD","SG9999002224.SGD","IE00BFXG1179.USD","BK4196","SGXZ57979304.SGD","IE00BJJMRX11.SGD","LU0472753341.HKD","LU1983260115.SGD","IE00BJJMRY28.SGD","LU0289960550.SGD","LU1791710400.SGD","LU1267930730.SGD","LU2236285917.USD","IE00B19Z8X17.USD","IE00B7KXQ091.USD","BK4567","LU0266013472.USD","BK4154","LU0426417589.USD","LU0211326755.USD","LU0965509010.AUD","LU2506952170.USD","SG9999014898.SGD","LU2087625088.SGD","LU1037948541.HKD","LU0109391861.USD","IE00BJT1NW94.SGD","LU0345770308.USD","LU2271345857.HKD","LU1983299246.USD","LU0965509283.SGD","SG9999014880.SGD","LU0094547139.USD","LU0976567544.SGD","BK4588","LU1732800096.USD","LU0203345920.USD","LU0528227936.USD","LU0553294199.USD","IE00B2B36J28.USD","LU1551013342.USD","LU1121112475.USD","IE00BSNM7G36.USD","IE00BZ9MQY76.HKD","BK4566","BK4121","LU0823416689.USD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU0203347892.USD","IE00BJJMRZ35.SGD","LU2552382132.HKD","LU1720051017.SGD","LU0708994859.HKD","LU1674673428.USD","LU2089283258.USD","LU2279689827.SGD","LU1267930227.SGD","LU0198837287.USD","LU1066051225.USD","LU2491049909.HKD","LU1548497426.USD","LU2244417387.USD","BK4534","IE00BKPKM429.USD","LU0683600562.USD","LU0882574055.USD","LU0211328371.USD","LU0965508806.USD","LU0795875169.SGD","LU1778281490.HKD","LU2361044949.HKD","LU0053666078.USD","LU2125154935.USD","LU1066051498.USD","LU2324357040.USD","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2605436625","title":"BRIEF-New England Journal Of Medicine Publishes Phase 3 Ascent-04/Keynote-D19 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2605436625","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605436625?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:18","pubTimestamp":1769033884,"startTime":"0","endTime":"0","summary":"BRIEF-New England Journal Of Medicine Publishes Phase 3 Ascent-04/Keynote-D19 Results Jan 21 (Reuters) - Gilead Sciences Inc GILD.O:NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES PHASE 3 ASCENT-04/KEYNOTE-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUA1BWJFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4566","LU1674673428.USD","LU2468319806.SGD","SG9999015952.SGD","LU0109394709.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE0002270589.USD","LU2324357040.USD","BK4568","LU0058720904.USD","BK4583","LU0823416689.USD","IE00BSNM7G36.USD","LU1430594728.SGD","IE00B3T34201.USD","LU2089984988.USD","BK4550","LU1066053197.SGD","LU1066051498.USD","SG9999015978.USD","IE00B19Z3581.USD","GILD","BK4139","SG9999015945.SGD","BK4532","LU0114720955.EUR","BK4585","LU1839511570.USD","LU1778281490.HKD","LU1585245621.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU2087621335.USD","BK4578","LU0234570918.USD","BK4588","LU0320765992.SGD","SG9999015986.USD","IE00B19Z3B42.SGD","LU0882574055.USD","LU1571399168.USD","LU1674673691.USD"],"gpt_icon":0},{"id":"2605436381","title":"Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2605436381","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605436381?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:07","pubTimestamp":1769033220,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Quest Diagnostics Inc.  slipped 2.28% to $184.65 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.16% to 6,875.62 and the Dow Jones Industrial Average  rising 1.21% to 49,077.23.This was the stock's third consecutive day of losses.Quest Diagnostics Inc. closed 6.53% below its 52-week high of $197.55, which the company reached on October 21st.The stock underperformed when compared to some of its competitors Wednesday, as UnitedHealth Group Inc.  rose 2.75% to $347.75, IQVIA Holdings Inc.  rose 3.30% to $241.40, and Centene Corp.  fell 1.09% to $45.26.Trading volume  eclipsed its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled January 21, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Do","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU0648000940.SGD","IE00BJJMRX11.SGD","LU2244417387.USD","LU0198837287.USD","LU1989764748.USD","DGX","LU0795875169.SGD","LU1854104046.USD","LU0648001328.SGD","LU1074936037.SGD","LU2133065610.SGD","LU2468319806.SGD","SG9999002224.SGD","LU0158827948.USD","LU0965509010.AUD","LU0354030511.USD","LU1670627923.USD","LU1934455863.HKD","IE00B2B36J28.USD","LU0965508806.USD","LU0820561818.USD","LU2360032135.SGD","LU1551013425.SGD","LU0128525929.USD","BK4534","BK4121","LU0251132253.USD","SG9999001176.SGD","LU1291159041.SGD","LU0496365809.HKD","LU0289739699.SGD","LU1732800096.USD","LU2552382132.HKD","LU0079474960.USD","LU0661504455.SGD","LU2324357040.USD","LU0353189680.USD","LU1778281490.HKD","LU2028103732.USD","IE00B7SZLL34.SGD","LU2357305700.SGD","SG9999014906.USD","SG9999014880.SGD","IE00B19Z8W00.USD","LU0130517989.USD","LU1496350502.SGD","LU0882574055.USD","LU2087625088.SGD","LU2089283258.USD","LU0107464264.USD","LU0077335932.USD","LU1988902786.USD","BK4566","LU0557290698.USD","LU0949170772.SGD","SG9999013999.USD","LU0149725797.USD","LU0823416689.USD","LU1201861249.SGD","LU0211326839.USD","LU1791710582.SGD","LU0965509101.SGD","LU0976567544.SGD","LU2506951875.HKD","LU0122379950.USD","LU0432979614.USD","BK4533","IE00B4JS1V06.HKD","LU1674673428.USD","LU1720051017.SGD","IE00BJJMRZ35.SGD","LU0943347566.SGD","LU2552382058.USD","LU1674673691.USD","LU0211327993.USD","IE0002270589.USD","LU0553294199.USD","LU0787776722.HKD","SG9999002232.USD","SGXZ99366536.SGD","BK4567","LU0130103400.USD","LU2264538146.SGD","LU0130102774.USD","IE00BKVL7J92.USD","LU1037948897.HKD","BK4196","LU0795875086.SGD","LU0048584097.USD","LU0158827781.USD","IE0002141913.USD","LU1267930227.SGD","LU0320765059.SGD","LU0965509283.SGD","LU0823417737.USD","LU1066051498.USD","LU2236285917.USD","LU2112291526.USD","LU1934455277.USD","SG9999014914.USD","LU2361045086.USD","LU1720051108.HKD","LU0109391861.USD","LU1066051225.USD","LU2506951958.HKD","LU1069347547.HKD","IE00BFSS8Q28.SGD","LU2211815571.USD","LU0211328371.USD","LU2491050154.USD","LU0345770308.USD","LU0689472784.USD","IE00B1BXHZ80.USD","LU0545039389.USD","LU0672654240.SGD","LU0053666078.USD","SG9999014898.SGD","LU0114720955.EUR","LU2362541273.HKD","BK4585","LU1934455194.USD","IE00B19Z9505.USD","LU1551013342.USD","LU1718418525.SGD","LU0029864427.USD","LU0708994859.HKD","SGXZ57979304.SGD","IE00BFXG1179.USD","LU0354030438.USD","LU0477156797.USD","LU2089984988.USD","LU0187121727.USD","LU0417517546.SGD","LU1035773651.USD","LU2125154935.USD","LU0310799852.SGD","LU0310800379.SGD","BK4588","LU1699723380.USD","IE00B1XK9C88.USD","IE0009355771.USD","LU0097036916.USD","LU0238689110.USD","LU1066053197.SGD","LU1983299246.USD","IE00B775H168.HKD","LU2111349929.HKD","LU0345770993.USD","LU0316494557.USD","LU0820562030.AUD","LU2347655156.SGD","LU1119994496.HKD","LU2362540622.SGD","LU1854103824.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0004445015.USD","LU0823417653.USD","LU1037948541.HKD","LU1057294990.SGD","IE00BFSS7M15.SGD","LU1084165304.USD","LU1201861165.SGD","LU0203347892.USD","LU1261432733.SGD","LU1548497426.USD","LU2279689827.SGD","IE00BZ1G4Q59.USD","LU2362541513.USD","LU2506952170.USD","LU1732799900.SGD","LU0256863811.USD","LU1023059063.AUD","SG9999018865.SGD","LU0234572021.USD","LU2506952097.USD","IE0004445239.USD","LU0310800965.SGD","LU2491049909.HKD","LU2271345857.HKD","IE00BN29S564.USD","LU0738911758.USD","LU0912757837.SGD","LU2552382215.SGD","LU1323610961.USD","LU2361044865.SGD","IE00B19Z9Z06.USD","IE00BSNM7G36.USD","LU0130518102.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0456855351.SGD","IE00B894F039.SGD","LU1153585028.USD","LU2461242641.AUD","SGXZ31699556.SGD","LU1670628061.USD","LU0477156953.USD","IE00BKPKM429.USD","LU2242649171.HKD","BK4154","IE00BWXC8680.SGD","IE00BZ9MQY76.HKD","LU1064131342.USD","LU1066051811.HKD","LU1914381329.SGD","BK4581","LU1003077747.HKD","LU2089284900.SGD","LU1506573853.SGD","SG9999001176.USD","BK4583","LU2125154778.USD","BK4532","IE00B7KXQ091.USD","IE00B19Z9P08.USD","SG9999018857.SGD","LU0950375773.USD","LU1267930730.SGD","LU1267930490.SGD","LU2491050071.SGD","SG9999017495.SGD","LU0342679015.USD","LU0094547139.USD","LU0052756011.USD","SGXZ81514606.USD","LU0980610538.SGD","IE00B19Z8X17.USD","LU0203345920.USD","IE00B4R5TH58.HKD","LU0353189763.USD","LU0708995401.HKD","LU0528227936.USD","LU0211326755.USD","LU1791710400.SGD","LU1989771016.USD","SGXZ51526630.SGD","LU1267930573.SGD","IE00B19Z3581.USD","IE00BJJMRY28.SGD","IE000M9KFDE8.USD","LU2023251221.USD","LU0683600562.USD","LU0266013472.USD","LU0820561909.HKD","LU2361044949.HKD","LU1814569148.SGD","IE0005OL40V9.USD","LU0011850046.USD","LU1989764664.SGD","BK4530","LU0128525689.USD","IE0034235188.USD","LU0861579265.USD"],"gpt_icon":0},{"id":"2605436140","title":"Gilead announces NEJM Phase 3 study data for Trodelvy+Keytruda","url":"https://stock-news.laohu8.com/highlight/detail?id=2605436140","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605436140?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:05","pubTimestamp":1769033126,"startTime":"0","endTime":"0","summary":"The company states: “Gilead (GILD) Sciences announced The New England Journal of Medicine published the full results from the positive Phase 3 ASCE...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-announces-nejm-phase-3-study-data-for-trodelvykeytruda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-announces-nejm-phase-3-study-data-for-trodelvykeytruda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SG9999001176.USD","LU1989772840.SGD","LU1941712348.USD","LU0122379950.USD","SG9999015986.USD","LU1116320901.HKD","BK4139","BK4532","LU0648001328.SGD","LU1674673691.USD","LU2361044949.HKD","LU0965509101.SGD","LU0320765646.SGD","LU0234572021.USD","LU1061106388.HKD","SG9999014542.SGD","LU1983299246.USD","LU0098860793.USD","LU0130517989.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU0203347892.USD","LU2023250843.SGD","BK4583","LU0823416689.USD","LU0980610538.SGD","SG9999002232.USD","LU2087621335.USD","BK4559","LU1989771016.USD","IE0002270589.USD","LU1934455863.HKD","LU1201861249.SGD","LU2106854487.HKD","LU1066051498.USD","SG9999015978.USD","BK4550","LU0106261372.USD","LU0211331839.USD","SG9999013999.USD","IE00B19Z3581.USD","IE0009355771.USD","IE00BBT3K403.USD","LU1057294990.SGD","BK4534","IE0002141913.USD","LU1934455194.USD","LU1162221912.USD","LU1430594728.SGD","IE000M9KFDE8.USD","LU1839511570.USD","LU2461242641.AUD","LU0130102774.USD","LU2324357040.USD","LU1571399168.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU1037948897.HKD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","BK4588","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU1066051811.HKD","IE00B7SZLL34.SGD","LU1929549753.HKD","LU0985320562.USD","SG9999014567.USD","LU1989772923.USD","SG9999015945.SGD","LU1093756168.USD","LU0006306889.USD","LU1941712264.USD","LU0882574055.USD","LU0234570918.USD","IE00BKVL7J92.USD","SG9999014575.USD","LU0265550359.USD","LU2361044865.SGD","LU1291159041.SGD","LU2112291526.USD","SG9999015341.SGD","LU2360032135.SGD","SG9999001440.SGD","LU0208291251.USD","LU1116320737.USD","LU2125154935.USD","LU2361045086.USD","LU1037948541.HKD","LU0320765489.SGD","LU0889565916.HKD","BK4578","LU1035773651.USD","LU1917777945.USD","LU0965508806.USD","LU1093756325.SGD","LU0265550946.USD","LU0266013472.USD","LU2089984988.USD","LU1066053197.SGD","BK4533","GILD","LU0320765992.SGD","LU0965509010.AUD","IE00B4R5TH58.HKD","SG9999001176.SGD","IE00BJT1NW94.SGD","LU1066051225.USD","SG9999014559.SGD","LU0238689110.USD","LU1934455277.USD","BK4568","LU0070302665.USD","LU1069347547.HKD","IE00B3T34201.USD","LU1585245621.USD","LU1974910355.USD","LU0109394709.USD","LU0965509283.SGD","BK4007","LU0477156953.USD","LU0203345920.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU0114720955.EUR","SG9999002224.SGD","LU2023250504.SGD","LU1699723380.USD","SG9999015952.SGD","LU0861579265.USD","LU0058720904.USD","BK4516","LU1023059063.AUD","IE00BN8TJ469.HKD","LU1674673428.USD","IE00BZ1G4Q59.USD","SG9999015358.SGD","BK4566","LU2125154778.USD","LU0289739699.SGD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2605350934","title":"Gilead's Trodelvy Plus Keytruda Improves Progression-Free Survival in First-Line PD-L1+ Metastatic TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2605350934","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605350934?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:00","pubTimestamp":1769032831,"startTime":"0","endTime":"0","summary":"Gilead Sciences Inc. announced the publication of full results from the Phase 3 ASCENT-04/KEYNOTE-D19 clinical trial in The New England Journal of Medicine. The study evaluated the efficacy and safety of Trodelvy  in combination with Keytruda  compared to Keytruda plus chemotherapy in patients with previously untreated, inoperable locally advanced or metastatic triple-negative breast cancer  whose tumors express PD-L1 . The ASCENT-04/KEYNOTE-D19 trial met its primary endpoint, with the combination of Trodelvy and Keytruda showing a 35% reduced risk of disease progression or death compared to the control group . Median progression-free survival was 11.2 months for the Trodelvy plus Keytruda group versus 7.8 months for the Keytruda plus chemotherapy group. The results were previously presented at the 2025 ASCO Annual Congress and the 2025 European Society for Medical Oncology Congress. Gilead has submitted supplemental applications for this indication to the U.S. Food and Drug Administra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDLbqWwF1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","LU1839511570.USD","LU1066053197.SGD","LU1674673428.USD","BK4588","IE00B3T34201.USD","SG9999015952.SGD","BK4566","LU0320765992.SGD","LU2324357040.USD","GILD","LU0289739699.SGD","IE00B7SZLL34.SGD","LU0882574055.USD","LU0823416689.USD","LU2089984988.USD","SG9999015986.USD","LU1571399168.USD","LU0234570918.USD","BK4139","LU0109394709.USD","LU0889565916.HKD","IE00BKVL7J92.USD","IE0002270589.USD","LU0114720955.EUR","LU2087621335.USD","IE00B19Z3581.USD","LU1674673691.USD","BK4532","BK4550","IE00BZ1G4Q59.USD","LU1778281490.HKD","LU1066051498.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","SG9999015978.USD","BK4568","LU1430594728.SGD","LU1585245621.USD","BK4583","LU0058720904.USD","LU2468319806.SGD","BK4585","SG9999015945.SGD"],"gpt_icon":0},{"id":"2605357064","title":"New England Journal of Medicine Publishes Phase 3 Ascent-04/Keynote-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-Line Pd-L1+ Metastatic Triple-Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2605357064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605357064?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:00","pubTimestamp":1769032800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUA1BWJFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","IE00B19Z3581.USD","BK4566","BK4583","BK4532","LU0823416689.USD","SG9999015978.USD","LU0114720955.EUR","LU1571399168.USD","LU0882574055.USD","LU0234570918.USD","BK4588","LU2468319806.SGD","LU0058720904.USD","BK4568","LU1066053197.SGD","LU1674673428.USD","LU1066051498.USD","LU0109394709.USD","IE0002270589.USD","LU1778281490.HKD","SG9999015945.SGD","BK4578","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU1430594728.SGD","LU1839511570.USD","BK4585","SG9999015986.USD","LU1674673691.USD","IE00BKVL7J92.USD","LU1585245621.USD","IE00BSNM7G36.USD","BK4139","LU0289739699.SGD","LU0889565916.HKD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU0320765992.SGD","SG9999015952.SGD","LU2087621335.USD","BK4550","GILD"],"gpt_icon":0},{"id":"2605343589","title":"Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2605343589","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605343589?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:36","pubTimestamp":1769031360,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 4.00% to $129.11 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.16% to 6,875.62 and the Dow Jones Industrial Average  rising 1.21% to 49,077.23.Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $128.70, which the company reached on November 20th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  fell 0.09% to $218.01, Pfizer Inc.  rose 1.45% to $25.89, and Abbott Laboratories  fell 0.34% to $120.73.Trading volume  eclipsed its 50-day average volume of 6.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled January 21, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF631.EUR","LU1066051498.USD","IE00B3T34201.USD","IE00BVYPNV92.GBP","LU1732800096.USD","LU2211815571.USD","LU0070217475.USD","LU0345769631.USD","LU0225771236.USD","LU2112291526.USD","SG9999002232.USD","LU2089984988.USD","LU0320765646.SGD","IE00BN8TJ469.HKD","LU1244550221.USD","LU1162221912.USD","LU0795875169.SGD","LU2471134796.USD","LU0985481810.HKD","BK4592","LU1894683348.USD","SG9999011175.SGD","LU2430703251.USD","LU0689626769.HKD","LU2129689605.HKD","LU0882574055.USD","LU0795875086.SGD","BK4504","BK4550","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU1989763690.USD","LU2129689431.USD","SG9999001176.USD","LU1261432733.SGD","LU1571399168.USD","BK4568","SG9999001440.SGD","LU2468319806.SGD","LU0345770308.USD","LU0683600562.USD","LU0114720955.EUR","LU1032466523.USD","LU1066051225.USD","IE00BFXG1179.USD","SG9999001176.SGD","LU0321505439.SGD","IE00B7SZLL34.SGD","LU0306806265.USD","LU1057294990.SGD","LU0456855351.SGD","LU0234572021.USD","LU2750360641.GBP","BK4559","SG9999015986.USD","LU0098860793.USD","LU1506573853.SGD","BK4599","LU2347655156.SGD","IE00B3PB1722.GBP","IE00BZ1G4Q59.USD","LU2133065610.SGD","IE0009355771.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU2602419157.SGD","SG9999015952.SGD","LU1691799644.USD","SG9999015945.SGD","LU1280957306.USD","LU1883839398.USD","LU1074936037.SGD","LU0124676726.USD","LU0170899867.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0787776722.HKD","IE00BVYPNW00.USD","LU1914381329.SGD","LU0234570918.USD","BK4007","BK4534","LU0225284248.USD","LU1196500208.SGD","IE00BLSP4452.SGD","LU1929549753.HKD","LU0889565916.HKD","LU1244550494.USD","BK4581","LU0640476718.USD","LU2471134879.HKD","LU1066051811.HKD","IE00B1BXHZ80.USD","LU0868494617.USD","BK4585","LU0432979614.USD","LU0823416689.USD","LU0203347892.USD","IE00BDGV0183.EUR","LU1066053197.SGD","LU0912757837.SGD","LU0466842654.USD","SGXZ57979304.SGD","LU2505996509.AUD","LU2324357040.USD","LU1061106388.HKD","LU1894683264.USD","LU2750360997.AUD","IE00B19Z3581.USD","IE00B42XCP33.USD","LU2237957811.SGD","SG9999002224.SGD","LU1674673691.USD","LU1839511570.USD","BK4532","LU1778281490.HKD","LU0792757196.USD","LU1059921491.USD","LU2129689514.USD","SGXZ41872573.SGD","IE00BLSP4239.USD","BK4533","BK4588","GILD","LU1718418525.SGD","LU1244550577.SGD","IE00B4R5TH58.HKD","IE0034235303.USD","LU0889566641.SGD","LU1585245621.USD","SG9999003800.SGD","SG9999015978.USD","LU0122379950.USD","IE0002270589.USD","LU0985320562.USD","LU2592432038.USD","LU1430594728.SGD","SG9999013999.USD","LU1989763427.SGD","SGXZ23171101.USD","LU1221951129.SGD","LU0203345920.USD","LU0321505868.SGD","LU1674673428.USD","LU1032955483.USD","LU1721429402.USD","LU1496350502.SGD","BK4578","LU0320765992.SGD","IE000M9KFDE8.USD","LU0058720904.USD","BK4139","LU1221951046.USD","IE00BJJMRZ35.SGD","LU1267930813.SGD","LU2471134952.CNY","SG9999004303.SGD","LU2505996681.GBP","IE00BBT3K403.USD","LU0345770993.USD","LU2237957902.USD","LU2471134523.USD","LU2087621335.USD","BK4566","LU1935042991.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","LU2430703178.SGD","BK4583","LU0266013472.USD","LU0306807586.USD","LU1732799900.SGD","LU1721429741.USD","LU2430703095.HKD","IE00BKVL7J92.USD","BK4082","LU0109394709.USD","LU0345769128.USD"],"gpt_icon":0},{"id":"2605433449","title":"Gilead Sciences Director Jeffrey Bluestone Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605433449","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605433449?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:26","pubTimestamp":1769030804,"startTime":"0","endTime":"0","summary":"Jeffrey Bluestone, Director at Gilead Sciences Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDLbqBGNB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences Director Jeffrey Bluestone Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1839511570.USD","GILD","LU0823416689.USD","LU2089984988.USD","LU0114720955.EUR","IE00BKVL7J92.USD","LU1674673428.USD","LU0289739699.SGD","LU0889565916.HKD","SG9999015986.USD","LU1571399168.USD","LU2087621335.USD","LU1066051498.USD","BK4139","BK4550","BK4578","LU1066053197.SGD","LU1585245621.USD","IE00B19Z3581.USD","SG9999015978.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU2468319806.SGD","LU0109394709.USD","LU0234570918.USD","LU2324357040.USD","LU1674673691.USD","BK4583","LU0058720904.USD","BK4568","LU0320765992.SGD","BK4585","BK4588","SG9999015952.SGD","IE00B3T34201.USD","LU1430594728.SGD","BK4532","LU1778281490.HKD","BK4566","IE0002270589.USD","SG9999015945.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2605102575","title":"GeoVax Labs Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605102575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605102575?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:55","pubTimestamp":1769000100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GOVX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 21, 2026 07:55 ET (12:55 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","GOVX"],"gpt_icon":0},{"id":"2605128959","title":"Bernstein Remains a Buy on Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605128959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605128959?lang=en_us&edition=fundamental","pubTime":"2026-01-21 08:07","pubTimestamp":1768954022,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences yesterday and set a price target of $135.00. According to TipRanks, Bre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-gilead-sciences-gild-blurbs-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-gilead-sciences-gild-blurbs-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","IE00B3T34201.USD","BK4583","LU1839511570.USD","LU2468319806.SGD","LU1571399168.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","GILD","SG9999015986.USD","IE00B7SZLL34.SGD","SG9999015978.USD","LU0889565916.HKD","BK4566","SG9999015952.SGD","BK4585","IE00BKVL7J92.USD","LU0289739699.SGD","LU0109394709.USD","LU1585245621.USD","LU0114720955.EUR","IE00B19Z3581.USD","LU0882574055.USD","LU1066051498.USD","BK4550","IE00BSNM7G36.USD","LU1430594728.SGD","LU2089984988.USD","SG9999015945.SGD","BK4568","BK4139","LU1066053197.SGD","LU0058720904.USD","BK4532","BK4588","IE0002270589.USD","BK4578","LU0234570918.USD","LU1674673428.USD","LU2324357040.USD","LU1674673691.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2605110440","title":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2605110440","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605110440?lang=en_us&edition=fundamental","pubTime":"2026-01-21 01:08","pubTimestamp":1768928883,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat loomsAdds details on Roche, Abbvie and CSL. Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4N3YL1OM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","LU2112291526.USD","LU0496365809.HKD","LU2089283258.USD","IE000M9KFDE8.USD","LU0738911758.USD","ABBV","LU1506573853.SGD","LU0077335932.USD","LU0256863811.USD","IE00B42XCP33.USD","LU1868836757.USD","LU0109394709.USD","LU1481599808.USD","IE00BSNM7G36.USD","LU2089284900.SGD","LU0225284248.USD","JNJ","LU1894683348.USD","SG9999011175.SGD","LU0477156953.USD","LU2023250843.SGD","LU1929549753.HKD","LU1880407132.USD","SG9999015978.USD","LU2168564495.EUR","LU1066051498.USD","BK4533","LU0029864427.USD","LU1883839398.USD","IE00B1BXHZ80.USD","LU1323610961.USD","BK4585","LU2091194634.USD","LU1116320737.USD","LU2461242641.AUD","BK7501","LU1623119135.USD","LU1720051108.HKD","LU1232071149.USD","LU0124676726.USD","LU0868494617.USD","LU0648001328.SGD","IE00BZ1G4Q59.USD","IE00BKPKM643.USD","IE00B19Z9P08.USD","LU2087625088.SGD","LU2264538146.SGD","BK4599","IE0004445015.USD","IE0002270589.USD","LU1720051017.SGD","AMGN","LU1221951046.USD","IE00BJJMRZ35.SGD","LU0057025933.USD","LU1093756325.SGD","LU0006306889.USD","LU0708994859.HKD","LU0058720904.USD","LU0171293334.USD","SG9999014575.USD","LU1699723380.USD","SGXZ81514606.USD","BIIB","LU0047473722.EUR","IE00BLSP4239.USD","AZN","IE0034235303.USD","LU1934455863.HKD","BK7067","IE00BKDWB100.SGD","LU0203201768.USD","LU1162221912.USD","LU1069347547.HKD","LU1267930813.SGD","LU1481600234.SGD","03165","PFE","LU0097036916.USD","LU1069344957.HKD","LU0640478417.SGD","LU1868837136.USD","LU1551013425.SGD","IE00B7SZLL34.SGD","LU1868836591.USD","LU0061475181.USD","LU0225771236.USD","LU1244550221.USD","SG9999014880.SGD","LU0170899867.USD","LU1084165304.USD","LU1196500208.SGD","LU0320765489.SGD","BK4566","LU0052756011.USD","LU0130102774.USD","LU0823434740.USD","IE00B775H168.HKD","LU0345770993.USD","LU0949170772.SGD","LU2236285917.USD","LU1153585028.USD","LU1585245621.USD","LU1035773651.USD","LU2023251221.USD","LU1496350171.SGD","LU1066051225.USD","LU0256863902.USD","LU0969580561.USD","LU2491049909.HKD","LU2237443382.USD","IE00B3T34201.USD","LU0689472784.USD","LU0047473722.SGD","IE00BJJMRX11.SGD","LU2471134796.USD","LU1051770623.HKD","IE00BBT3K403.USD","LU1066051811.HKD","LU0784385840.USD","IE00B19Z3B42.SGD","LU0316494557.USD","LU0757432116.USD","SG9999014559.SGD","LU1104425308.USD","LU2237443549.SGD","LU1019634622.SGD","LU1804176565.USD","IE00BK4W5L77.USD","LU1718418525.SGD","LU0069063385.USD","LU0122379950.USD","LU0345769631.USD","GB00BDT5M118.USD","LU1078025761.USD","LU0321505868.SGD","SNY","LU1061106388.HKD","LU1019632923.USD","IE00B19Z3581.USD","CSL.AU","LU1732799900.SGD","LU2293690082.USD","LU2746668974.SGD","LU0211326839.USD","SG9999002232.USD","LU0321505439.SGD","LU0786609619.USD","LU0266013472.USD","LU0345777659.USD","LU2293690249.USD","LU1032955483.USD","SG9999014567.USD","IE0009355771.USD","LU0203347892.USD","LU1244550577.SGD","LU1674673428.USD","LU1814569148.SGD","LU1712237335.SGD","LU1778281490.HKD","IE00BKPKM429.USD","LU2168564065.EUR","LU0310799852.SGD","GILD","LU0353189763.USD","LU0976567544.SGD","LU1974910355.USD","LU0784383803.USD","LU0997586432.USD","IE00B1XK9C88.USD","LU1989771016.USD","BK4550","LU1170363599.USD","BK4578","SG9999014914.USD","BK4534","IE0002141913.USD","SG9999015986.USD","LU2471134952.CNY","LU1221951129.SGD","LU0985320562.USD","LU2133065610.SGD","LU2360106947.USD","LU0985481810.HKD","IE00BJLML261.HKD","LU1989772840.SGD","BK4007","LU2491050154.USD","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","SG9999015945.SGD","LU0289961442.SGD","LU1868837300.USD","LU2471134523.USD","LU2491050071.SGD","IE00B4JS1V06.HKD","LU2750360641.GBP","LU1066053197.SGD","LU2430703178.SGD","LU1941712264.USD","BK7508","LU0943347566.SGD","LU0471298694.HKD","LU0689626769.HKD","LU1988902786.USD","LU0963555726.SGD","LU1015430645.USD","LU0526926950.USD","LU2430703095.HKD","BK4516","LU0889565080.SGD","LU2168564222.USD","LLY","LU2361044865.SGD","LU0208291251.USD","LU1280957306.USD","LU2237443895.HKD","LU1035775433.USD","LU1496350502.SGD","IE00BJJMRY28.SGD","LU1487256676.USD","LU1064131342.USD","LU0857590862.USD","LU0784385170.HKD","IE00B19Z9Z06.USD","SG9999015341.SGD","LU0417517546.SGD","IE00BKVL7J92.USD","LU1934455277.USD","IE00B3PB1722.GBP","LU1868836914.USD","LU2242652126.USD","LU0661504455.SGD","LU0472753341.HKD","LU0306807586.USD","IE00B4R5TH58.HKD","IE00BFSS7M15.SGD","LU2129689605.HKD","LU1267930490.SGD","IE00BK4W5M84.HKD","LU0471298777.SGD","LU2361045086.USD","IE0004445239.USD","LU1839511570.USD","LU0456855351.SGD","LU2125154935.USD","LU1037948897.HKD","BK4504","LU2087621335.USD","LU0820561818.USD","SG9999014906.USD","SG9999017495.SGD","LU1291159041.SGD","LU2357305700.SGD","LU0557290698.USD","LU1153584641.USD","LU0079474960.USD","LU1674673691.USD","LU0225283273.USD","SG9999001440.SGD","LU1917777945.USD","LU1935042991.SGD","LU2552382215.SGD","IE00BFXG1179.USD","LU0823399737.USD","LU2750360997.AUD","LU1003076772.USD","LU0158827948.USD","BK4559","LU0972486137.USD","LU2063271972.USD","LU0238689110.USD","LU2360032135.SGD","IE00BFSS8Q28.SGD","BK4568","LU1074936037.SGD","LU1366192091.USD","LU1037948541.HKD","RHHBY","LU0784384876.USD","IE00BGHQF631.EUR","LU0096364046.USD","SG9999013999.USD","LU1551013342.USD","LU2456880835.USD","LU1983299246.USD","SG9999003800.SGD","LU0114720955.EUR","LU0823416689.USD","LU0203202063.USD","LU0211327993.USD","LU0965509101.SGD","LU0354030511.USD","LU2237443622.USD","LU0320765992.SGD","LU2114397693.USD","LU1571399168.USD","LU1059921491.USD","LU0106261372.USD","BK4592","IE00BWXC8680.SGD","LU1301847155.USD","LU0432979614.USD","LU0960981461.USD","LU1548497426.USD","MRK","LU0265550359.USD","LU0882574139.USD","LU2108987350.USD","LU0320765646.SGD","LU1023059063.AUD","LU2279689827.SGD","LU2462157665.USD","LU2592432038.USD","LU0345770308.USD","IE0005OL40V9.USD","LU0795875086.SGD","NVS","LU0323591593.USD","IE00B7KXQ091.USD","LU1941712348.USD","LU2125154778.USD","LU1267930573.SGD","LU0640476718.USD","LU2505996509.AUD","LU0011850046.USD","LU0920840948.USD","LU0683600562.USD","LU0965509283.SGD","LU0795875169.SGD","IE00BLSP4452.SGD","LU1934455194.USD","LU2361044949.HKD","BK4532","LU0882574055.USD","LU1127390331.HKD","LU2602419157.SGD","LU0198837287.USD","LU2023250504.SGD","IE00BVYPNV92.GBP","LU0385154629.USD","LU1093756168.USD","LU0128525689.USD","LU2324357040.USD","LU2471134879.HKD","LU0920783379.SGD","LU2168564149.EUR","BK4139","LU2237443978.SGD","BK4581","LU0234570918.USD","LU2237438978.USD","BK5011","LU1267930227.SGD","LU1003077747.HKD","LU1064927863.SGD","LU0965509010.AUD","LU1430594728.SGD","LU0708995401.HKD","LU0889565916.HKD","LU2089984988.USD","LU2552382058.USD","SG9999014898.SGD","SG9999015952.SGD","LU1119994496.HKD","IE00BFTCPJ56.SGD","LU0265550946.USD","LU0949170426.SGD","LU1914381329.SGD","LU2347655156.SGD","LU0310800379.SGD","LU0070217475.USD","LU0889566641.SGD","LU2168563687.JPY","LU1261432733.SGD","LU2106854487.HKD","LU0553294199.USD","LU2539964713.USD","BK7511","LU0466842654.USD","LU2417539215.USD","LU0511384066.AUD","LU1989772923.USD","LU1057294990.SGD","LU0289739699.SGD","LU0827474353.SGD","LU2746668461.USD","LU0861579265.USD","LU0211328371.USD","LU2211815571.USD","LU1116320901.HKD","LU0098860793.USD","LU1732800096.USD","LU0787776722.HKD","SG9999015358.SGD","SG9999001176.SGD","LU0672654240.SGD","LU2552382132.HKD","LU0980610538.SGD","LU1267930730.SGD","LU2242646821.SGD","LU0499090636.EUR","LU2430703251.USD","SGXZ51526630.SGD","IE00B894F039.SGD","LU2129689431.USD","LU0345769128.USD","LU1244550494.USD","LU2237443465.HKD","LU0345777147.USD","LU1894683264.USD","LU0820561909.HKD","SG9999002224.SGD","LU0965508806.USD","SG9999018857.SGD","LU0957799991.USD","LU0130517989.USD","BK4588","LU0203345920.USD","04332","LU2468319806.SGD","LU0094547139.USD","LU0306806265.USD","LU0289739343.SGD","LU0575583348.USD","LU0310800965.SGD","LU0354030438.USD","LU1201861249.SGD","LU2265009873.SGD","LU0320765059.SGD","SGXZ99366536.SGD","IE00B2B36J28.USD","LU1032466523.USD","SG9999018865.SGD","LU0964806797.USD","LU0070302665.USD","LU0234572021.USD","LU2129689514.USD","IE00BN29S564.USD","LU1880407215.USD","IE00BN8TJ469.HKD","LU0128525929.USD","LU0211331839.USD","LU0353189680.USD","LU0912757837.SGD","SG9999014542.SGD","LU0545039389.USD","LU2505996681.GBP","SG9999001176.USD","SGXZ31699556.SGD","IE00BVYPNW00.USD","LU0211326755.USD","SGXZ57979304.SGD","IE0034235188.USD","LU0823434583.USD","LU0792757196.USD","BK4583"],"gpt_icon":1},{"id":"2604311621","title":"Viatris Launches Inpefa in United Arab Emirates","url":"https://stock-news.laohu8.com/highlight/detail?id=2604311621","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604311621?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:54","pubTimestamp":1768917280,"startTime":"0","endTime":"0","summary":"Viatris  said Tuesday that it has launched Inpefa, or sotagliflozin, to treat heart failure in the United Arab Emirates.The company said future launches are planned in multiple countries over the next several years.The drug is intended to treat adults with heart failure or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits, Viatris said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU1839511570.USD","BK4583","VTRS","BK4588","BK4007","UBCP","BK4211","LU2087621335.USD"],"gpt_icon":0},{"id":"2604819010","title":"BRIEF-Viatris Launches Inpefa, Expanding Its Heart Failure Portfolio And Broadening Presence In Cardiovascular Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2604819010","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604819010?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:10","pubTimestamp":1768911051,"startTime":"0","endTime":"0","summary":"BRIEF-Viatris Launches Inpefa, Expanding Its Heart Failure Portfolio And Broadening Presence In Cardiovascular DiseasesJan 20  - Viatris Inc VTRS.O:VIATRIS EXPANDS INNOVATIVE PORTFOLIO IN CARDIOVASCULAR DISEASES WITH THE COMPANY'S FIRST LAUNCH OF INPEFA  FOR THE TREATMENT OF HEART FAILURESource text: [ID:]Further company coverage: VTRS.O  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","BK4007","LU2087621335.USD","BK4585","VTRS","BK4583","BK4588"],"gpt_icon":0},{"id":"2604972921","title":"Viatris Expands Innovative Portfolio in Cardiovascular Diseases With the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2604972921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604972921?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:59","pubTimestamp":1768910397,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU1839511570.USD","LU2087621335.USD","VTRS","BK4007","BK4588","BK4583"],"gpt_icon":0},{"id":"2604123449","title":"Gilead Sciences Chief Commercial Officer Johanna Mercier Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2604123449","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604123449?lang=en_us&edition=fundamental","pubTime":"2026-01-17 07:11","pubTimestamp":1768605070,"startTime":"0","endTime":"0","summary":"Johanna Mercier, Chief Commercial Officer of Gilead Sciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDLFB38D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences Chief Commercial Officer Johanna Mercier Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B3T34201.USD","BK4588","IE00B7SZLL34.SGD","LU2087621335.USD","LU0058720904.USD","LU0882574055.USD","LU1839511570.USD","LU2089984988.USD","BK4583","LU2468319806.SGD","LU1585245621.USD","SG9999015986.USD","LU0234570918.USD","LU1674673691.USD","LU1778281490.HKD","LU2324357040.USD","LU1066053197.SGD","BK4566","BK4139","BK4585","LU0320765992.SGD","LU1674673428.USD","IE00BKVL7J92.USD","GILD","BK4550","IE00B19Z3581.USD","LU1066051498.USD","LU1430594728.SGD","IE00BZ1G4Q59.USD","BK4532","LU0114720955.EUR","LU0823416689.USD","SG9999015952.SGD","BK4578","IE00BSNM7G36.USD","LU0109394709.USD","LU0289739699.SGD","SG9999015978.USD","BK4568","LU0889565916.HKD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2604829911","title":"Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2604829911","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604829911?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:35","pubTimestamp":1768599300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 3.01% to $124.91 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.06% to 6,940.01 and Dow Jones Industrial Average  falling 0.17% to 49,359.33.Gilead Sciences Inc. closed 2.94% short of its 52-week high of $128.70, which the company reached on November 20th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 0.41% to $218.66, Pfizer Inc.  fell 0.93% to $25.65, and Abbott Laboratories  fell 1.43% to $121.76.Trading volume  eclipsed its 50-day average volume of 6.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled January 16, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","LU0889565916.HKD","LU1066051498.USD","LU0306806265.USD","LU1267930813.SGD","LU2133065610.SGD","LU0289739699.SGD","LU1718418525.SGD","SG9999001176.SGD","LU2471134952.CNY","LU1721429402.USD","LU0114720955.EUR","LU1057294990.SGD","LU0345770308.USD","LU0098860793.USD","LU1066053197.SGD","IE00BFXG1179.USD","LU0234572021.USD","LU1721429741.USD","IE00BN8TJ469.HKD","LU2430703178.SGD","LU0882574055.USD","LU2112291526.USD","IE00BKVL7J92.USD","LU1839511570.USD","LU0683600562.USD","SG9999002232.USD","LU0345769631.USD","LU0306807586.USD","LU2237957902.USD","LU1989763690.USD","LU0321505868.SGD","LU0889566641.SGD","LU2211815571.USD","IE0009355771.USD","LU2505996509.AUD","LU1732799900.SGD","BK4588","LU1032466523.USD","BK4532","LU2750360997.AUD","BK4578","IE0002270589.USD","SG9999001176.USD","IE00BBT3K403.USD","LU0787776722.HKD","LU2602419157.SGD","LU1061106388.HKD","IE00B19Z3B42.SGD","SGXZ23171101.USD","LU2089984988.USD","LU2324357040.USD","LU0689626769.HKD","IE0034235303.USD","LU0225284248.USD","LU1032955483.USD","SG9999015945.SGD","LU2087621335.USD","LU0795875086.SGD","LU2750360641.GBP","IE00BVYPNV92.GBP","LU0823416689.USD","LU1914381329.SGD","LU1023059063.AUD","LU1674673691.USD","LU2471134523.USD","LU0640476718.USD","LU0203345920.USD","LU1261432733.SGD","BK4007","LU1571399168.USD","BK4533","LU0225771236.USD","LU2129689605.HKD","BK4585","LU0266013472.USD","LU2430703251.USD","IE00BJJMRZ35.SGD","BK4568","LU0109394709.USD","SG9999003800.SGD","LU2129689514.USD","SG9999013999.USD","LU2430703095.HKD","BK4566","LU1244550577.SGD","IE00BGHQF631.EUR","LU0456855351.SGD","LU0345770993.USD","LU1066051225.USD","LU2471134879.HKD","LU1894683264.USD","LU2505996681.GBP","IE00BJT1NW94.SGD","BK4504","LU1585245621.USD","IE00BDGV0183.EUR","IE00B7SZLL34.SGD","LU2347655156.SGD","BK4592","SG9999015986.USD","LU1929549753.HKD","IE00BVYPNW00.USD","LU1935042991.SGD","SG9999004303.SGD","BK4139","IE00B1BXHZ80.USD","LU0466842654.USD","IE00B3T34201.USD","LU1221951046.USD","LU0795875169.SGD","LU0122379950.USD","LU0432979614.USD","IE00B19Z3581.USD","LU1244550494.USD","LU1506573853.SGD","BK4599","GILD","LU2592432038.USD","LU1883839398.USD","LU0321505439.SGD","LU0985320562.USD","IE00BSNM7G36.USD","BK4559","LU1674673428.USD","BK4581","LU0070217475.USD","LU1280957306.USD","LU1162221912.USD","LU0868494617.USD","BK4583","IE00BFTCPJ56.SGD","IE00B42XCP33.USD","LU1496350502.SGD","IE00B3PB1722.GBP","LU1691799644.USD","SG9999011175.SGD","LU0124676726.USD","LU0345769128.USD","LU1074936037.SGD","BK4550","SG9999015952.SGD","IE00B4R5TH58.HKD","LU0985481810.HKD","LU1221951129.SGD","IE00BZ1G4Q59.USD","IE00BLSP4239.USD","LU1244550221.USD","LU0203347892.USD","LU0792757196.USD","LU2471134796.USD","LU0234570918.USD","LU0320765646.SGD","LU2129689431.USD","LU1066051811.HKD","LU0170899867.USD","LU1430594728.SGD","SG9999001440.SGD","SGXZ41872573.SGD","SGXZ57979304.SGD","LU1894683348.USD","LU1196500208.SGD","LU1778281490.HKD","LU0912757837.SGD","BK4082","BK4534","IE0002141913.USD","IE00BLSP4452.SGD","LU1059921491.USD","LU1989763427.SGD","IE00B2B36J28.USD","LU2237957811.SGD","LU2468319806.SGD","LU0320765992.SGD","SG9999002224.SGD","LU1732800096.USD","LU0058720904.USD","IE000M9KFDE8.USD"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0203},{"period":"6month","weight":0.0758},{"period":"1year","weight":0.1366},{"period":"ytd","weight":0.0051}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction